Immunovia AB (publ) (LON:0G8X)
London flag London · Delayed Price · Currency is GBP · Price in SEK
0.2000
-0.0090 (-4.31%)
At close: Feb 3, 2026

Immunovia AB Revenue

Immunovia AB had revenue of 101.00K SEK in the quarter ending September 30, 2025, a decrease of -57.02%. This brings the company's revenue in the last twelve months to 786.00K, up 24.37% year-over-year. In the year 2024, Immunovia AB had annual revenue of 931.00K, down -40.89%.

Revenue (ttm)
786.00K SEK
Revenue Growth
+24.37%
P/S Ratio
160.33
Revenue / Employee
65.50K SEK
Employees
12
Market Cap
9.95M GBP

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024931.00K-644.00K-40.89%
Dec 31, 20231.58M430.00K37.55%
Dec 31, 20221.15M301.00K35.66%
Dec 31, 2021844.00K482.00K133.15%
Dec 31, 2020362.00K6.00K1.69%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca43.64B
GSK plc32.67B
Haleon11.02B
Smith & Nephew4.33B
IXICO6.53M
RUA Life Sciences4.11M
CelLBxHealth2.62M
Verici Dx1.40M
Revenue Rankings